One expert says the the Federal Trade Commission’s complaint is itself enough to kill the proposed deal.
Move over, Siri and Alexa. WellBe is here to take the virtual assistant market to new heights with at-home healthcare support.
Castle Creek Biosciences is developing several treatments that may provide relief for “Butterfly Children” and others living with rare genetic diseases.
Venatorx Pharmaceuticals is leading the race to develop new antibiotics before the next drug-resistant superbug spreads.
With an innovative curriculum, the partnership offers faster paths to careers in the growing sector.
Ocugen has developed a new platform that could help bring greater attention to underserved areas of ophthalmology.
Repisodic has developed a technology solution to help patients and their families make smarter, faster decisions about post-acute care.
With a $100 million investment, MRA Group hopes to turn the suburban research campus into an energy-efficient innovation hub.
The local company is developing solutions that can improve treatment and outcomes for cancer patients.
Einstein Medical Center is one of the first hospitals in the nation to allow visitors to register to vote with kiosks on site.
The company wants to eradicate suicide by creating technologies that improve the bond between mental health patients and their providers.
It is the first baby born as part of Penn Medicine’s ongoing trial to help women give birth following uterus transplantation.
Patients can access the testing service to determine how they might respond to various psychiatric drugs.
Verix Health is developing a suite of steerable surgical needles to enable minimally invasive treatment of hard-to-reach cancer tumors.
From pivotal clinical trials to major partnerships, these five Philly companies made the most of 2019. Here’s what they’ve got planned for 2020.